Financial Performance - The company's operating revenue for 2021 reached ¥5,549,906,816.60, representing a year-on-year increase of 63.12%[22]. - The net profit attributable to shareholders for 2021 was ¥1,479,380,288.82, reflecting a significant growth of 151.28% compared to the previous year[22]. - The net cash flow from operating activities increased by 103.94% year-on-year, amounting to ¥1,410,612,292.25, primarily due to rising product prices and increased net profit[25]. - Total assets grew by 37.83% year-on-year, reaching ¥10,153,035,662.82, driven by enhanced profitability and increases in cash, investments, and inventory[25]. - Basic earnings per share for 2021 were ¥3.18, up 150.39% from the previous year, attributed to substantial growth in operating revenue and profit[25]. - The weighted average return on equity increased by 12.66 percentage points to 23.59% in 2021, indicating improved profitability[22]. - The net profit after deducting non-recurring gains and losses rose by 184.62% year-on-year to ¥1,376,145,702.21, driven by significant revenue growth[25]. - The company reported a net profit of ¥446,499,750.48 in Q4 2021, showing a steady increase throughout the year[26]. - The company experienced a net cash flow from operating activities of -¥218,166,559.40 in Q4 2021, indicating fluctuations in cash flow management[26]. Dividend and Share Capital - The company plans to distribute a cash dividend of 10 CNY per 10 shares, totaling 464,564,135 CNY, and will increase its share capital by 185,825,654 shares through a capital reserve conversion, raising total shares to 650,389,789[7]. - The company has a cash dividend policy that prioritizes cash dividends, aiming for a minimum of 30% of the average distributable profit over three consecutive years to be distributed in cash when conditions are met[166]. - The company approved a profit distribution plan for 2021, proposing a cash dividend of 10 RMB per 10 shares (including tax) and a capital reserve conversion of 4 shares for every 10 shares, totaling a cash distribution of 464,564,135 RMB and an increase in total shares to 650,389,789[171]. Risk Management - The company reported no significant risks that could materially affect its operations during the reporting period[8]. - The company has outlined various risks and countermeasures in its management discussion and analysis section[8]. - The company has a comprehensive risk management strategy in place to address potential operational challenges[8]. - The company has no non-operating fund occupation by controlling shareholders or related parties[8]. - The company has no violations of decision-making procedures regarding external guarantees[8]. Audit and Compliance - The audit report issued by Rongcheng Accounting Firm confirmed the financial statements' authenticity and completeness, with a standard unqualified opinion[6]. - The company has established a strict internal control management system in compliance with regulations, ensuring legal and compliant operations and asset security[176]. - The company has disclosed its internal control audit report, which received a standard unqualified opinion[178]. - The company has not faced any penalties from securities regulatory agencies in the past three years[145]. Market and Industry Position - The global pesticide market demand remained strong in 2021 due to post-pandemic monetary easing and increased focus on food security, leading to a rise in pesticide demand[35]. - The company's sales growth was driven by the release of new production capacity, strong domestic and international market demand, and increased product prices due to rising raw material costs[41]. - The company is one of the few listed firms capable of large-scale production of ortho-nitrochlorobenzene and is a major production base for the fungicide carbendazim[40]. - The domestic pesticide industry has seen steady growth in sales and profits, with the company benefiting from the resilience of the pesticide supply chain amid global economic challenges[39]. - The company has a competitive edge in the market due to its comprehensive production system and a wide range of pesticide products[42]. Research and Development - Research and development expenses increased by 54.18% to CNY 278,518,554.68, indicating a commitment to innovation[53]. - The company has developed and mastered several production technologies, including DAP/HAP impurity control technology and thiocyanate reaction technology[48]. - The company is committed to sustainable development and improving the quality and efficiency of its operations[112]. - The company aims to enhance its research and development capabilities in response to industry trends and regulatory changes, particularly in the chemical sector[82]. - The company has invested in R&D since its establishment, with a technology center that has undertaken multiple national science and technology projects, resulting in numerous patents and recognition as a high-tech enterprise[96]. Environmental Responsibility - The company has established a wastewater treatment plant with a daily processing capacity of 5,000 tons, effectively treating high-salinity and low-salinity wastewater[188]. - The wastewater treatment process includes advanced methods such as iron-carbon micro-electrolysis and multi-effect evaporation, ensuring compliance with discharge standards[190]. - Emissions from the thermal power boiler are within regulatory limits, with sulfur dioxide at 5.803 mg/m³, nitrogen oxides at 23.772 mg/m³, and particulate matter at 0.133 mg/m³[186]. - The company has implemented comprehensive noise control measures, including the use of low-noise equipment and sound insulation techniques[189]. - The company has a robust hazardous waste management system, ensuring compliance with regulations and proper disposal of hazardous materials[193]. - The company has actively pursued green development initiatives, focusing on waste reduction and energy efficiency improvements[200]. - The company has established a carbon emission management system to promote energy efficiency and reduce greenhouse gas emissions[200]. Governance and Management - The board of directors has ensured that all members attended the board meeting, affirming the report's accuracy and completeness[5]. - The management team includes experienced professionals with backgrounds in finance, technology, and management, contributing to strategic decision-making[134]. - The board of directors is composed of individuals with diverse professional experiences, enhancing governance and oversight capabilities[136]. - The company emphasizes a people-oriented approach to human resource development, aiming to create a supportive work environment and attract talent[116]. - The company has a structured employee compensation system based on positions, with annual performance bonuses as a supplement, and provides benefits such as social insurance and paid leave[161]. Production and Operations - The company achieved a production capacity of 26.1 million tons per year with a utilization rate of 74.54%[100]. - The company has a land reserve of 4,200 acres across its two production bases, providing a strong foundation for future expansion[85]. - The company has established a complete R&D, procurement, production, testing, and sales system, adopting an "order-driven + safety stock" business model[86]. - The company’s main products, including multi-bacterial agents and methyl thiophanate, rank among the top in domestic production and sales, with high profit margins in the industry[92]. Shareholder Engagement - The company actively communicates with shareholders, especially small shareholders, to gather their opinions and address their concerns regarding cash dividends[170]. - The company is committed to encouraging participation from small and institutional investors in profit distribution decisions, leveraging professional guidance from intermediaries[170]. - The company has a mechanism in place to deduct cash dividends from shareholders who have illegally occupied company funds[170].
广信股份(603599) - 2021 Q4 - 年度财报